IGF2 and cancer: IGFBP6, a specific inhibitor of insulin-like growth factor II (IGF-II), exhibits significantly stronger binding capacity to IGF-II than to IGF-I and can effectively inhibit the proliferation of malignant tumors with high IGF-II expression [39].